Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts

Endocrinology

Volumn 140, Issue 6, 1999, Pages 2439-2451

  Bodine, Peter V N ^a   Harris, Heather A ^a   Komm, Barry S ^a  

^a WYETH AYERST RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LUCIFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL CULTURE; CHO CELL; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033279170     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.6.6612     Document Type: Article

References (57)

1. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
2. Pathogenesis of osteoporosis
3. Cytokines and estrogen in bone: Anti-osteoporotic effects
4. Treatment of postmenopausal osteoporosis
5. Skeletal effects of estrogen
6. Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis
7. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblastic cells in vitro: A potential mechanism for the anti-osteoporotic effect of estrogens
8. Involvement of CCAAT/enchancer binding protein and nuclear factor-κB binding sites in interleukin-6 promoter inhibition by estrogens
9. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ
10. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors
11. The NF-κB and IκB proteins: New discoveries and insights
12. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism
13. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high-affinity DNA binding by the estrogen receptor
14. Functional properties of a conditionally-phenotypic, estrogen-responsive, human osteoblast cell line
15. Development and characterization of a conditionally-transformed adult human osteoblastic cell line
16. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblastic phenotype
17. Endogenous protein kinase-C activation in osteoblast-like cells modulates responsiveness to estrogen and estrogen receptor levels
18. Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talk
19. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene
20. Estrogen response in the hFOB1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene
21. 2 formation
22. Modulation by vitamin B6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addition to the glucocorticoid receptor
23. The regulation and expression of MHC class I genes
24. Estrogen receptor-α is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression
25. ERβ: Identification and characterization of a novel human estrogen receptor
26. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
27. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens
28. Control of progesterone receptors in fetal uterine cells in culture: Effects of estradiol, progestins, antiestrogens, and growth factors
29. Antiestrogens antagonize the stimulatory effect of epidermal growth factor on the induction of progesterone receptor in fetal uterine cells in culture
30. Anti-steroidal and anti-growth factor activities of anti-estrogens
31. Stimulation of progesterone receptors by phorbol ester and cyclic AMP in fetal uterine cells in culture
32. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen
33. Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors
34. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor
35. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I
36. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: A comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-I, and serum factors
37. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
38. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
39. A novel nuclear form of estradiol receptor in MCF-7 human breast cancer cells
40. Hormonal regulation of osteoclast function
41. gp130 and the interleukin-6 family of cytokines
42. Transforming growth factor-β gene family members and bone
43. Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women
44. Circulating levels of interleukin-6 and transforming growth factor-α are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - A clinical research center study
45. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells
46. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor
47. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site
48. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth
49. Tumor necrosis factor-α modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro
50. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells
51. Cross-talk between nuclear factor-κB and the steroid hormone receptors: Mechanisms of mutual antagonism
52. Clinical review 83: Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis
53. Oestradiol inhibits the release of tumor necrosis factor but not interleukin-6 from adult human osteoblasts in vitro
54. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: Lack of regulation by 17β-estradiol
55. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1β and tumor necrosis factor-α is not regulated by ovarian steroids